Medikit Co.,Ltd. (TYO:7749)

Market Cap	36.41B
Revenue (ttm)	22.33B
Net Income (ttm)	3.09B
Shares Out	14.62M
EPS (ttm)	208.82
PE Ratio	11.92
Forward PE	n/a
Dividend	90.00 (3.58%)
Ex-Dividend Date	Mar 28, 2025

Volume	3,200
Average Volume	5,190
Open	2,488.00
Previous Close	2,514.00
Day's Range	2,481.00 - 2,550.00
52-Week Range	2,362.00 - 3,175.00
Beta	0.24
RSI	43.01
Earnings Date	May 15, 2025

About Medikit

Medikit Co.,Ltd. engages in the manufacture and sale of vascular access medical devices. The company offers IV catheters, such as Supercath 5, Supercath Z3V, and Supercath Ztu-V; hemodialysis products, including Supercath PRO, Supercath NEO, and Supercath Clampcath; and intervention products comprising Supersheath and Mongoose. Its products are used in anesthetic departments, operating theaters, ICUs, and dialysis and cardiology units. The company markets its products through distributors in approximately 20 countries and territories in the Eur...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1973
• Employees: 966
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 7749

Financial Performance

In 2023, Medikit's revenue was 21.85 billion, an increase of 1.12% compared to the previous year's 21.61 billion. Earnings were 3.07 billion, an increase of 7.16%.